NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002170

Registered date:08/07/2009

The Clinical Significance of Plasma Pentraxin 3 levels for Patients with Diastolic Heart Failure

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with heart failure
Date of first enrollment2006/06/01
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe clinical significance of plasma PTX3 levels for patients with left ventricular diastolic dysfunction
Secondary Outcomecardiovascular events, which were a composite of CV death, non-fatal myocardial infarction or ischemic stroke, unstable angina, hospitalization for HF, or coronary revascularization.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaExclusion criteria include active systemic inflammatory diseases, chronic renal failure requiring hemodialysis, active hepatic diseases, collagen diseases, presence of malignant tumor or acute coronary syndrome within 3 months preceding admission.

Related Information

Contact

public contact
Name Junichi Matsubara
Address 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, Japan Japan
Telephone 096-373-5175
E-mail j-matsu@kumamoto-u.ac.jp
Affiliation Faculty of Life Sciences, Kumamoto University Department of Cardiovascular Medicine
scientific contact
Name Hisao Ogawa
Address 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, Japan Japan
Telephone 096-373-5175
E-mail ogawah@kumamoto-u.ac.jp
Affiliation Faculty of Life Sciences, Kumamoto University Department of Cardiovascular Medicine